Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

Men given two larger doses of radiation had about the same side effects as others treated with the standard five-dose course, ...

Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...

Doctor explains minimally invasive laser procedure removes enlarged prostate, reduces bleeding, and prevents kidney failure ...

Approximately one in eight American men will be diagnosed with prostate cancer during their lifetime. For most of them, if ...

A treatment option for prostate cancer patients is now available in the Midstate. The UPMC Hillman Cancer Center in Harrisburg can now provide HDR, or high-dose rate prostate ...

Key Points Interested in Candel Therapeutics, Inc.? Here are five stocks we like better. Candel Therapeutics said it remains on track to file a BLA by year-end for aglatimagene in localized prostate ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

A new podcast fronted by writer, comedian and broadcaster Jon Holmes is aiming to help men better understand their prostate cancer treatment options ...